Business Description
Guangdong Winsun Bio Pharmaceutical Co Ltd
ISIN : CNE100003YV5
Compare
Compare
Traded in other countries / regions
839729.China IPO Date
2020-07-27Description
Guangdong Winsun Bio Pharmaceutical Co Ltd is involved in the field of veterinary biological products. It is an enterprise integrating research and development, production, sales, and service of veterinary biological products. It engages in the production of embryotoxin live vaccines, cytotoxic live vaccines, bacterial live vaccines, avian influenza inactivated vaccines, cytotoxic inactivated vaccines, embryotoxin inactivated vaccines, bacterial inactivated vaccines, swine fever live vaccines (rabbit source); veterinary use Biological products.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.23 | |||||
| Equity-to-Asset | 0.82 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | 0.88 | |||||
| Interest Coverage | 40.39 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 9.14 | |||||
| Beneish M-Score | -3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 49 | |||||
| 3-Year EBITDA Growth Rate | 46 | |||||
| 3-Year EPS without NRI Growth Rate | 39.5 | |||||
| 3-Year FCF Growth Rate | 24.7 | |||||
| 3-Year Book Growth Rate | -1.1 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.38 | |||||
| 9-Day RSI | 40.35 | |||||
| 14-Day RSI | 40.73 | |||||
| 6-1 Month Momentum % | 73.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.51 | |||||
| Quick Ratio | 4.28 | |||||
| Cash Ratio | 0.28 | |||||
| Days Inventory | 120.26 | |||||
| Days Sales Outstanding | 144.93 | |||||
| Days Payable | 181.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.59 | |||||
| Dividend Payout Ratio | 1.29 | |||||
| Forward Dividend Yield % | 2.59 | |||||
| 5-Year Yield-on-Cost % | 2.64 | |||||
| Shareholder Yield % | 5.01 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 57.19 | |||||
| Operating Margin % | 12.52 | |||||
| Net Margin % | 11.19 | |||||
| FCF Margin % | 26.91 | |||||
| ROE % | 4.44 | |||||
| ROA % | 3.67 | |||||
| ROIC % | 5.22 | |||||
| ROC (Joel Greenblatt) % | 6.55 | |||||
| ROCE % | 4.93 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 58.79 | |||||
| PE Ratio without NRI | 46.19 | |||||
| Shiller PE Ratio | 22.34 | |||||
| Price-to-Owner-Earnings | 411.25 | |||||
| PEG Ratio | 30.79 | |||||
| PS Ratio | 6.63 | |||||
| PB Ratio | 2.72 | |||||
| Price-to-Tangible-Book | 2.98 | |||||
| Price-to-Free-Cash-Flow | 24.31 | |||||
| Price-to-Operating-Cash-Flow | 23.26 | |||||
| EV-to-EBIT | 54.27 | |||||
| EV-to-EBITDA | 54.27 | |||||
| EV-to-Revenue | 6.85 | |||||
| EV-to-FCF | 25.45 | |||||
| Price-to-Projected-FCF | 2.01 | |||||
| Price-to-Graham-Number | 2.56 | |||||
| Price-to-Net-Current-Asset-Value | 4.25 | |||||
| Earnings Yield (Greenblatt) % | 1.84 | |||||
| FCF Yield % | 3.92 | |||||
| Forward Rate of Return (Yacktman) % | -3.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Guangdong Winsun Bio Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 261.724 | ||
| EPS (TTM) (Â¥) | 0.11 | ||
| Beta | 1.19 | ||
| Volatility % | 57.18 | ||
| 14-Day RSI | 40.73 | ||
| 14-Day ATR (Â¥) | 0.470825 | ||
| 20-Day SMA (Â¥) | 7.3835 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (Â¥) | 4.66 - 10.29 | ||
| Shares Outstanding (Mil) | 273.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Guangdong Winsun Bio Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Guangdong Winsun Bio Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Guangdong Winsun Bio Pharmaceutical Co Ltd Frequently Asked Questions
What is Guangdong Winsun Bio Pharmaceutical Co Ltd(BJSE:839729)'s stock price today?
The current price of BJSE:839729 is ¥6.92. The 52 week high of BJSE:839729 is ¥10.29 and 52 week low is ¥4.66.
When is next earnings date of Guangdong Winsun Bio Pharmaceutical Co Ltd(BJSE:839729)?
The next earnings date of Guangdong Winsun Bio Pharmaceutical Co Ltd(BJSE:839729) is .
Does Guangdong Winsun Bio Pharmaceutical Co Ltd(BJSE:839729) pay dividends? If so, how much?
The Dividend Yield %  of Guangdong Winsun Bio Pharmaceutical Co Ltd(BJSE:839729) is 2.59% (As of Today), Highest Dividend Payout Ratio of Guangdong Winsun Bio Pharmaceutical Co Ltd(BJSE:839729) was 2.86. The lowest was 0.85. And the median was 1.19. The  Forward Dividend Yield % of Guangdong Winsun Bio Pharmaceutical Co Ltd(BJSE:839729) is 2.59%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers